Sustained-release and swelling characteristics of xanthan gum/ethylcellulose-based injection moulded matrix tablets: In vitro and in vivo evaluation

Journal of Pharmaceutical Sciences

Volumn 100, Issue 7, 2011, Pages 2858-2870

  Quinten, T ^a   De Beer, T ^a   Onofre, F O ^b   Mendez Montealvo, G ^b   Wang, Y J ^b   Remon, J P ^a   Vervaet, C ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF ARKANSAS   (United States)

Author keywords

Bioavailability; Controlled release; Formulation; Gels; Oral drug delivery; Physical characterization; Polymeric drug delivery systems; Processing; Solid dispersion; Solid dosage form

Indexed keywords

DICHLOROMETHANE; ETHYL CELLULOSE; METOPROLOL TARTRATE; PLASTICIZER; SEBACIC ACID DIBUTYL ESTER; UNCLASSIFIED DRUG; XANTHAN; XANTURAL;

ARTICLE; IN VITRO STUDY; IN VIVO STUDY; MATRIX TABLET; SUSTAINED DRUG RELEASE; SWELLING; X RAY DIFFRACTION;

EID: 79955623038     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22480     Document Type: Article

References (31)

1. Crowley MM, Zhang F, Repka MA, Thumma S, Upadhye SB, Battu SK, McGinity JW, Martin C. 2007. Pharmaceutical applications of hot-melt extrusion: Part 1. Drug Dev Ind Pharm 33:909-926.
2. De Brabander C, Vervaet C, Remon JP. 2003. Development and evaluation of sustained release mini-matrices prepared via hot-melt extrusion. J Control Rel 89:235-247.
3. Albers J, Alles R, Matthée K, Knop K, Nahrup JS, Kleinebudde P. 2009. Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion. Eur J Pharm Biopharm 71:387-394.
4. Young CR, Crowley M, Dietzsch C, McGinity JW. 2007. Physicochemical properties of film-coated melt-extruded pellets. J Microencapsul 24:57-71.
5. Crowley MM, Fredersdorf A, Schroeder B, Kucera S, Prodduturi S, Repka MA, McGinity JW. 2004. The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films. Eur J Pharm Sci 22:409-418.
6. Deng J, Li L, Stephans D, Tian Y, Robinson D. 2004. Effect of postmolding heat treatment on in vitro properties of a polyanhydride implant containing gentamicin sulfate. Drug Dev Ind Pharm 30:341-346.
7. El-Agakey MA, Soliva M, Speiser P. 1971. Hot extruded dosage forms. Part I. Technology and dissolution kinetics of polymeric matrices. Pharm Acta Helv 46:31-52.
8. Rothen-Weinhold A, Besseghir K, Vuaridel E, Sublet E, Oudry N, Kubel F, Gurny R. 1999. Injection-molding versus extrusion as manufacturing technique for the preparation of biodegradable implants. Eur J Pharm Biopharm 48:113-121.
9. Cheng L, Guo S, Weiping W. 2009. Characterization and in vitro release of praziquantel from poly(ε-caprolactone) implants. Int J Pharm 377:112-119.
10. Li CL, Deng J. 2002. Polyanhydride implant for antibiotic delivery-from the bench to the clinic. Adv Drug Deliv Rev 54:963-986.
11. Vaz CM, van Doeveren PFNM, Reis RL, Cunha AM. 2003. Soy matrix drug delivery systems obtained by melt-processing techniques. Biomacromolecules 4:1520-1529.
12. Cuff G, Raouf F. 1998. A preliminary evaluation of injection moulding as a technology to produce tablets. Pharm Technol 6:96-106.
13. Eith L, Stepto RFT, Tomka I, Wittwer F. 1986. The injection-moulded capsule. Drug Dev Ind Pharm 12:2113-2126.
14. Quinten T, De Beer T, Vervaet C, Remon JP. 2009. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets. Eur J Pharm Biopharm 71:145-154.
15. Quinten T, Gonnissen Y, Adriaens E, De beer T, Cnudde V, Masschaele B, Van Hoorebeke L, Siepmann J, Remon JP, Vervaet C. 2009. Development of injection moulded matrix tablets based on mixtures of ethylcellulose and low-substituted hydroxypropylcellulose. Eur J Pharm Sci 37:207-216.
16. Quinten T, De Beer T, Almeida A, Vlassenbroeck J, Van Hoorebeke L, Remon JP, Vervaet C. 2010. Development and evaluation of injection-molded sustained-release tablets containing ethylcellulose and polyethylene oxide. Drug Dev Ind Pharm. doi: 10.3109/03639045.2010.498426.
17. Follonier N, Doelker E, Cole ET. 1994. Evaluation of hot-melt extrusion as a new technique for the production of polymer-based pellets for sustained-release capsules containing high loadings of freely soluble drugs. Drug Dev Ind Pharm 20:1323-1339.
18. Talukdar MM, Michoel A, Rombaut P, Kinget R. 1996. Comparative study on xanthan gum and hydroxypropylmethyl cellulose as matrices for controlled-release drug delivery. I. Compaction and in-vitro drug release behavior. Int J Pharm 129:233-241.
19. Ritger RL, Peppas NS. 1987. A simple equation for disposition of solute release. II. Fickian and anomalous release from swellable devices. J Control Release 5:37-42.
20. Onofre FO, Wang J. 2010. Hydroxypropylated starches of varying amylose contents as sustained release matrices in tablets. Int J Pharm 385:104-112.
21. Blomqvist I, Westergren G, Sandberg A, Jonsson UE, Lundborg P. 1988. Pharmacokinetics and pharmacodynamics of controlled release metoprolol: A comparison with atenolol. Eur J Clin Pharmacol 33:S19-S24.
22. Sandberg A, Ragnarsson G, Jonsson UE, Sjögren J. 1988. Design of a new multiple-unit controlled release formulation of metoprolol. Eur J Clin Pharmacol 33:S3-S7.
23. Fang J, Semple HA, Song J. 2004. Determination of metoprolol, and its four metabolites in dog plasma. J Chromatogr B Analyt Technol Biomed Life Sci 809:9-14.
24. Gohel MC, Bariya SH. 2009. Fabrication of triple-layer matrix tablets of venlafaxine hydrochloride using xanthan gum. AAPS PharmSciTech 10:624-630.
25. Talukdar M, Plaizier-Vercammmen J. 1993. Evaluation of xanthan gum as a hydrophilic matrix for controlled-release dosage form preparations. Drug Dev Ind Pharm 19:1037-1046.
26. Talukdar M, Vinckier I, Moldenaers P, Kinget, R. 1996. Rheological characterization of xanthan gum and hydroxypropylmethylcellulose with respect to controlled-release drug delivery. J Pharm Sci 85:537-540.
27. Almdal K, Dyre J, Hvidt S, Kramer O. 1993. Towards a phenomenological definition of the term 'gel'. Polym Gels Netw 1:5-17.
28. Colombo P, Bettini R, Massimo G, Catellani PL, Santi P, Peppas NA. 1995. Drug diffusion front movement is important in drug release control from swellable matrix tablets. J Pharm Sci 84:991-997.
29. Siepmann J, Kranz H, Bodmeier R, Peppas NA. 1999. HPMC-matrices for controlled drug delivery: A new model combining diffusion, swelling, and dissolution mechanism and predicting the release kinetics. Pharm Res 16:1748-1756.
30. Siepmann J, Peppas NA. 2001. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 48:139-157.
31. Kararli TT. 1995. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos 16:351-380.